Login / Signup

The effect of inhaled corticosteroids on the outcomes of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.

Chao-Hsien ChenCheng-Yi WangYa-Hui WangChing-Yi ChenKuang-Hung ChenChih-Cheng LaiYu-Feng WeiChih-Cheng Lai
Published in: Expert review of clinical pharmacology (2022)
In patients with mild-to-moderate COVID-19, ICS therapy improved symptom resolution, and decreased the risk of needing urgent medical care or hospitalization.
Keyphrases
  • coronavirus disease
  • sars cov
  • cystic fibrosis
  • single molecule
  • respiratory syndrome coronavirus
  • patient reported
  • metabolic syndrome
  • skeletal muscle
  • bone marrow